Future studies will be necessary to investigate whether overexpressing active XBP1 could prevent the decline of anti-oxidant capacity in aged RPE and to identify small molecules that can enhance XBP1 activity to protect RPE cells from oxidative damage during AMD. The gene discussed is XBP1; the disease is age-related macular degeneration.